NFL is a marker of treatment response in children with SMA treated with nusinersen

ConclusionsNusinersen normalized the axonal damage marker NFL and correlated with motor improvement in children with SMA. NFL may, therefore, be a novel biomarker to monitor treatment response early in the disease course.
Source: Journal of Neurology - Category: Neurology Source Type: research